Manufacturer record
Globin Pharmaceuticals Pvt. Ltd. Puhana Chowk: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Globin Pharmaceuticals Pvt. Ltd. Puhana Chowk (Uttarakhand) was declared Not of Standard Quality in December 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GI-049, VOVEZAL-3 (Diclofenac Sodium Injection I.P.) (exp Mar 2023). RDTL Guwahati (state lab) found it not of standard quality: pH and Assay Content of Diclofenac Sodium. Listed in the December 2022 alert.
Records by type
1 record linked to Globin Pharmaceuticals Pvt. Ltd. Puhana Chowk in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| VOVEZAL-3 (Diclofenac Sodium Injection I.P.) | Batch GI-049Mfg Apr 2021 · Exp Mar 2023 | pH and Assay Content of Diclofenac SodiumAssay | RDTL GuwahatiState lab | Dec 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.